Carin Espenschied

Company: Guardant Health

Job title: Director, Global Scientific Affairs

Seminars:

Panel Discussion: Supercharging Oncology Therapeutics with Unprecedented Patient Surveillance to Provide Insights On Risk of Relapse & Improve Survival 3:45 pm

Leveraging MRD to act as a biomarker for patient relapse Developing surrogate endpoints using ctDNA Investigating the potential of multi-markers in advancing patient monitoringRead more

day: Day One